期刊文献+

双参数磁共振成像技术对前列腺癌的诊断价值 被引量:3

The value of biparametric magnetic resonance imaging technology in the diagnosis of prostate cancer
在线阅读 下载PDF
导出
摘要 目的:探讨双参数磁共振成像(biparametric magnetic resonance imaging,Bp-MRI)技术对前列腺癌(prostate cancer,PCa)的诊断价值。方法:回顾性收集2019年1月-2021年12月广东省中医院二沙岛医院收治的182例前列腺疾病患者,两名医师采用双参数磁共振成像(Bp-MRI)技术、多参数磁共振成像(multiparameter magnetic resonance imaging,Mp-MRI)技术、T_(2)加权联合动态增强磁共振成像技术在未知病理情况下分别对患者进行前列腺影像报告和数据系统(PI-RADS)评分,以病理结果为金标准,对比分析各影像技术对PCa的诊断效能。结果:两名医师使用Bp-MRI、Mp-MRI、T_(2)WI-DCE技术诊断PCa的AUC值分别为0.88、0.90、0.84,其中,Bp-MRI诊断PCa灵敏度、特异度为0.83、0.86,Mp-MRI为0.85、0.85,T_(2)WI-DCE为0.73、0.88,Bp-MRI与T_(2)WI-DCE的AUC差异具有统计学意义(P<0.05),Bp-MRI与Mp-MRI的AUC差异无统计学意义(P>0.05)。结论:Bp-MRI技术对PCa具有良好的诊断价值,在某些条件下,将Bp-MRI技术作为Mp-MRI技术的备选方案是可行的。 Objective To investigate the diagnostic value of biparametric magnetic resonance imaging(Bp-MRI)technology in prostate cancer(PCa).Methods A total of 182 patients with prostate diseases admitted to Ersha Island Branch of Guangdong Provincial Hospital of Chinese Medicine from January 2019 to December 2021 were collected.Two radiologists used biparametric magnetic resonance imaging(Bp-MRI)technology,MultiParameter magnetic resonance imaging(Mp-MRI)technology and T_(2)-weighted combined dynamic contrast-enhanced magnetic resonance imaging technology to evaluate the prostate imaging reporting and data system(PI-RADS)scores of the above patients without pathological results.The pathological results were used as the gold standard to compare the diagnostic efficacy of each imaging technology for PCa.Results The AUC values of Bp-MRI,Mp-MRI and T_(2)WI-DCE in the diagnosis of PCa by two radiologists were 0.88,0.90 and 0.84,respectively.The sensitivity and specificity of Bp-MRI in the diagnosis of PCa were 0.83 and 0.86,and those of Mp-MRI were 0.85 and 0.85,respectively,T_(2)WI-DCE was 0.73 and 0.88.The difference of AUC between Bp-MRI and T_(2)WI-DCE was statistically significant(P<0.05),but the difference of AUC between Bp-MRI and Mp-MRI was not statistically significant(P>0.05).Conclusion Bp-MRI technology exhibits a robust diagnostic value for PCa,suggesting that it may be a feasible to use Bp-MRI as an alternative to Mp-MRI under specific conditions.
作者 胡应锋 钟治平 林俊坤 林文宇 陈英杰 HU Yingfeng;ZHONG Zhiping;LIN Junkun;LIN Wenyu;CHEN Yingjie(Department of Radiology,Ersha Island Branch of Guangdong Provincial Hospital of Chinese Medicine,Guangzhou,Guangdong 510000,China)
出处 《影像研究与医学应用》 2023年第10期57-60,64,共5页 Journal of Imaging Research and Medical Applications
关键词 双参数磁共振成像技术 前列腺癌 前列腺影像报告和数据系统2.1版 Biparametric magnetic resonance imaging Prostate cancer Prostate Imaging-Reporting and Data System Version 2.1
  • 相关文献

参考文献10

二级参考文献83

  • 1张文杰,毛宁,谢海柱,段绍峰,张学喜,王滨.基于多参数MR影像组学方法预测前列腺癌患者骨转移[J].临床放射学杂志,2020,39(6):1122-1126. 被引量:11
  • 2张翀宇,芮文斌,祝宇,刘定益,吴瑜璇,周文龙,沈周俊.经会阴前列腺穿刺484例分析[J].中国男科学杂志,2007,21(3):40-43. 被引量:13
  • 3EtzioniR, Penson DF, Legler JM, et al. Overdiagnosis due toprostate-specific antigen screening : lessons from U. S. prostatecancer incidence trend [J]. J Natl Cancer Inst, 2002,94(13):981 -990.
  • 4Iremashvili V, Pelaez L,Manoharan M, et al. Pathologic prostatecancer characteristics in patients eligible for active surveillance : ahead-to-head comparison of contemporary protocols [ J ]. EurUrol, 2012, 62(3): 462-468.
  • 5Bastian PJ, Carter BH, Bjartell A, et al. Insignificant prostatecancer and active surveillance ; from definition to clinical implica-tions [J]. Eur Urol, 2009, 55(6) : 1321 -1332.
  • 6Tosoian JJ, Trock BJ, Landis P, et al. Active surveillance pro-gram for prostate cancer : an update of the Johns Hopkinsexperience[ J]. J Clin Oncol, 2011, 29(16) : 2185 -2190.
  • 7Adamy A, Yee DS, Matsushita K, et al. Role of prostate specificantigen and immediate confirmatory biopsy in predicting progres-sion during active surveillance for low risk prostate cancer [ J]. JUrol, 2011,185(2) : 477 -482.
  • 8Van den Bergh RC,Roemeling S,Roobol MJ, et al. Outcomes ofmen with screen-detected prostate cancer eligible for active surveil-lance who were managed expectantly [ J]. Eur Urol, 2009, 55(1): 1 -8.
  • 9Whitson JM, Porten SP,Hilton JF, et al. The relationship be-tween prostate specific antigen change and biopsy progression inpatients on active surveillance for prostate cancer [ J]. J Urol,2011,185(5) : 1656 -1660.
  • 10Soloway MS, Soloway CT, Eldefrawy A, et al. Careful selectionand close monitoring of low-risk prostate cancer patients on activesurveillance minimizes the need for treatment [ J ]. Eur Urol,2010, 58(6): 831 -835.

共引文献71

同被引文献19

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部